@article{ARH3666,
author = {Mark L. Metersky and Yi Huang},
title = {Ketolide antibiotics: will they ever be used for community-acquired pneumonia?},
journal = {Annals of Research Hospitals},
volume = {1},
number = {4},
year = {2017},
keywords = {},
abstract = {There is no perfect antibiotic for community-acquired pneumonia (CAP). β-lactams do not cover atypical organisms, most importantly, Legionella. Fluoroquinolones remain active against Streptococcus pneumoniae and cover atypical bacteria, but are associated with serious side effects including tendon rupture and a variety of neurologic side effects.},
issn = {2523-0743}, url = {https://arh.amegroups.org/article/view/3666}
}